(STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it presented promising data from its Phase 1 clinical study ...

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has unveiled promising preclinical data for ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...

CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib, which help slow cancer cell division. Immunotherapy: For some patients with triple-negative breast cancer (which lacks hormone receptors ...

Claire Turner, 43 was diagnosed in January, learning that the disease had spread to her liver, thighs, lymph nodes and ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Advances in Cancer Treatment: How cutting-edge treatments are changing outcomes Cancer treatment is undergoing a ...

Terry Reddick, 75, who lives in Doncaster, was diagnosed with advanced kidney cancer two and a half years ago. He was referred to the new immunotherapy Late Effects service in May 2024 after suffering ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...